Syncromune® Appoints Industry Veteran Kerri-Ann Millar as Chief Financial Officer to Advance Corporate Growth Initiatives and Clinical Development ProgramMillar to Lead Financial Strategy as Syncromune Scales Development of the SYNC-T® Novel Immunotherapy Platform for Solid Tumor CancersFORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, June 16, 2025 (GLOBE NEWSWIRE) --...